{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-059526","form_type":"8-K","ticker":"AIDX","cik":"0001139685","company_name":"20/20 Biolabs, Inc.","filed_at":"2026-05-20T20:10:53+00:00","discovered_at":"2026-05-20T20:12:00.256989+00:00","generated_at":"2026-05-20T21:36:31.414074+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"20/20 BioLabs Q1 revenue $0.4M, net loss $2.2M; expects Q2 rebound from firefighter programs","bullets":["Q1 revenue $0.4M vs $0.6M YoY; net loss $2.2M vs $0.8M; gross margin 17.8% vs 29.9%.","Cash $4.2M (vs $1.0M Dec 2025) after $5M private placement; deferred revenue $0.5M.","State-funded firefighter cancer screening programs expected to drive meaningful Q2 revenue; second state committed.","Launched OneTest for Longevity with IBM; exclusive U.S. CKD license from ROKIT Healthcare.","Medicare MCED Screening Act signed Feb 2026; pathway for Medicare coverage by 2028."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-059526","json":"https://secwatch.observer/filing/0001213900-26-059526.json","markdown":"https://secwatch.observer/filing/0001213900-26-059526.md","text":"https://secwatch.observer/filing/0001213900-26-059526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/0001213900-26-059526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/ea0291642-8k_2020bio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T21:36:31.414074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"47714a5ddbecd00fbb2949883b91f43d173da466","claim":"20/20 Biolabs, Inc. reported the first quarter ended March 31, 2026 results: revenue $0.4 million.","evidence_excerpt":"Total revenue for the three months ended March 31, 2026 was $0.4 million, compared to $0.6 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026059526/0001213900-26-059526-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$0.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}